Divis Labs, Lupin, Dr Reddy's, Glenmark: Check fresh targets for Pharma stocks post Q3
Pharma companies under Choice Institutional Equities' coverage delivered a strong performance during the recent quarter, with average year-on-year (YoY) revenue rising by 12.8 per cent.
Pharma companies under Choice Institutional Equities' coverage delivered a strong performance during the recent quarter, with average year-on-year (YoY) revenue rising by 12.8 per cent.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
